52 Week Range
As of on the NASDAQ ∙ Minimum 15 minute delay
3M AVG Volume
52 Week High
52 Week Low
Shares Out (MIL)
Market Cap (MIL)
Dividend (Yield %)
Moderna To Deliver 25 Mln Doses Of Its COVID-19 Vaccine To Australia
Moderna Reports Qtrly EPS Of $2.84
Moderna Expands Manufacturing Technology Center In Massachusetts
Moderna, Inc. is engaged in transformative medicines based on messenger ribonucleic acid (mRNA). It has created a platform to improve the underlying pharmaceutical properties of our mRNA medicines. Its platform consists of three areas: mRNA technologies, delivery technologies, and manufacturing processes. It is pursuing mRNA science to minimize the undesirable activation of the immune system by mRNA and to maximize the potency of mRNA once in the target cells. It has advanced in parallel a diverse development pipeline of 21 programs, of which 10 have entered clinical studies and another three have open INDs. Its therapeutics and vaccine development programs span infectious diseases, oncology, cardiovascular diseases, and rare genetic diseases. It has created six modalities prophylactic vaccines, cancer vaccines, intratumoral immmuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics and systemic intracellular therapeutics.
Biotechnology & Drugs
200 Technology Sq
Noubar B. Afeyan
Non-Executive Independent Chairman of the Board, Co-Founder
Chief Executive Officer, Director
David W. Meline
Chief Financial Officer
Chief Human Resources Officer
Price To Earnings (TTM)
Price To Sales (TTM)
Price To Book (MRQ)
Price To Cash Flow (TTM)
Total Debt To Equity (MRQ)
LT Debt To Equity (MRQ)
Return on Investment (TTM)
Return on Equity (TTM)
Australia is in "active talks" with COVID-19 vaccine maker Moderna Inc to establish a domestic manufacturing facility for shots, Health Minister Greg Hunt said on Thursday, the day after securing 25 million doses from the company.
Australia is in "active talks" with COVID-19 vaccine maker Moderna Inc to establish a domestic manufacturing facility for mRNA vaccines, Health Minister Greg Hunt said on Thursday.
The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.
Australia on Wednesday tapped Moderna Inc for 25 million COVID-19 vaccine doses, as it tries to speed up vaccination in people under 50 after deciding against AstraZeneca, whose jab has been linked to rare blood clots.
Moderna Inc on Wednesday announced a supply pact with Australia for 25 million doses of its COVID-19 vaccine, of which 10 million doses against the original strain of the virus are to be delivered in 2021. (Reporting by Manojna Maddipatla in Bengaluru; Editing by Arun Koyyur...
Japan's government may approve the use of coronavirus vaccines developed by AstraZeneca PLC and Moderna Inc as early as May 20, the Nikkei reported on Friday.
Moderna Inc on Thursday said it believes countries around the globe would continue buying its COVID-19 vaccine for years even if patents on the shots are waived, noting that rivals would face significant hurdles in scaling up manufacturing.
Moderna Inc said on Thursday that waiving intellectual property rights on COVID-19 vaccines will not help boost supply in 2021 or 2022, a day after U.S. President Joe Biden backed a proposed waiver that is aimed at giving poorer companies access. (Reporting by Manas Mishra...
Moderna Inc raised its 2021 sales forecast for its COVID-19 vaccine by 4.3% to $19.2 billion on Thursday, reflecting demand from countries looking to return to normalcy through rapid inoculation.
Moderna Inc said on Wednesday early human trial data shows that a third dose of either its current COVID-19 shot or an experimental new vaccine candidate increases immunity against variants of COVID-19 first found in Brazil and South Africa.
The Philippines' food and drug agency approved on Wednesday the emergency use of U.S. drugmaker Moderna Inc's COVID-19 vaccine in the Southeast Asian nation.
* WHO boss heralds "suberb gesture", urges others to follow Sweden
Moderna will supply 34 million doses of its COVID-19 vaccine this year and Sweden has donated 1 million AstraZeneca shots to the global COVAX programme, a small boost as it struggles to get stocks to inoculate the world's poorest people.
* Three lines for Moderna vaccine expected to hit capacity by June
Three new Lonza production lines that manufacture ingredients for Moderna's COVID-19 vaccine are due to be producing at capacity by the end of June, Chief Executive Pierre-Alain Ruffieux said on Thursday in an interview.
Spanish contract drugmaker Rovi said on Thursday it will double its capacity to bottle COVID-19 vaccines for Moderna.
* MODERNA INC - ANNOUNCES ADDITIONAL INVESTMENTS TO INCREASE GLOBAL SUPPLY FOR COVID-19 VACCINE TO UP TO 3 BILLION DOSES IN 2022
Contract drug manufacturer Lonza plans to double Swiss production capacity for Moderna's COVID-19 vaccine, helping the U.S. drugmaker boost total output to as many as 3 billion doses in 2022. (Reporting by John Miller Editing by Riham Alkousaa)
Moderna Inc said on Wednesday the U.S. government had agreed to increase the contract for the company's COVID-19 vaccine by $236 million to roughly $1.25 billion, to include additional costs related to the shot's studies.
Drugmaker Lonza Group, under pressure to find workers to help speed production of Moderna Inc's COVID-19 vaccine, is recruiting temporary employees from food giant Nestle to staff Swiss plants making ingredients for the shot, state broadcaster RTS said on Tuesday, citing...
Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.